Optomease 200mg/ml concentrate for solution for fish treatment
Optomease 200mg/ml concentrate for solution for fish treatment
Authorised
- Benzocaine
Product identification
Medicine name:
Optomease 200mg/ml concentrate for solution for fish treatment
OPTOMEASE δερματικό διάλυμα, πυκνό 200 MG/ML
Active substance:
- Benzocaine
Target species:
-
Atlantic salmon
-
Trout
Route of administration:
-
Water-borne use
Product details
Active substance and strength:
-
Benzocaine200.00/milligram(s)/millilitre1.00millilitre(s)
Pharmaceutical form:
-
Concentrate for solution for fish treatment
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- bottle of 125 ml
- bottle of 1000 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Biofaktor Sp. z o.o.
- Naqua Limited
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 128370/21-12-2020 (K-0234401)
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0370/001
Concerned member states:
-
Denmark
-
Greece
-
Ireland
-
Norway
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
eu-PUAR-optomease-200mg-ml-concentrate-for-solution-for-fish-treatment-en.pdf
English (PDF)
Download Published on: 12/04/2023
